NCI-Designated vs Comprehensive Cancer Center — what the designations mean

When people say a hospital is “an NCI cancer center,” they can mean several different things. The designation matters — but the levels and tiers are easy to confuse. Here’s a plain-language breakdown.

What is NCI designation?

The National Cancer Institute (NCI) is part of the U.S. National Institutes of Health. Its Cancer Centers Program has designated cancer centers since 1971, when the National Cancer Act created the framework.

There are 71 NCI-designated cancer centers across 37 states. Designation is awarded through a peer-reviewed grant process and renewed every 5 years. It recognizes institutions that meet rigorous scientific and clinical standards — not every hospital that treats cancer qualifies.

The three tiers

NCI recognizes three types of designated centers:

1. Basic Laboratory Cancer Centers (7 centers)

Focused primarily on laboratory research. These centers do not necessarily provide direct patient care — they contribute to the cancer research ecosystem through discovery science.

2. Cancer Centers (12 centers)

Focused on one or two of the three research areas NCI recognizes — basic, clinical, or population science — but not all three. They provide patient care, run clinical trials, and contribute to research.

3. Comprehensive Cancer Centers (57 centers — the highest designation)

Must demonstrate excellence across all three research areas:

• Basic laboratory research — understanding cancer biology
• Clinical research — testing new therapies in patients
• Population research — studying cancer across populations, disparities, prevention

Comprehensive Cancer Centers also must demonstrate substantial community outreach and education programs. This is the most demanding designation and represents the top tier of U.S. cancer care.

See our full list of NCI-designated cancer centers, organized by state.

What does designation mean for patients?

An NCI designation is not a promise that every patient will have a better outcome at that center. But it’s a reliable signal of several things:

• Research volume — designated centers run more clinical trials, giving patients access to experimental therapies
• Multidisciplinary care — tumor boards involving medical, surgical, and radiation oncology, plus pathology and imaging
• Subspecialty expertise — at major comprehensive centers, there’s often a physician who focuses exclusively on a specific cancer type
• Academic affiliation — most are tied to a medical school; they train the next generation of oncologists

When an NCI center matters more

Consider seeking care or a second opinion at an NCI-designated center if:

• You have a rare or uncommon cancer (sarcoma, mesothelioma, adrenocortical carcinoma, inflammatory breast cancer, etc.)
• Your cancer has unusual molecular features
• You’re facing a complex or high-risk treatment decision
• Standard treatment has failed and you want trial access
• You want a second opinion from a subspecialty expert

Most NCI centers offer virtual second opinions — you don’t have to travel to benefit from their expertise.

When it matters less

For common cancers being treated with standard-of-care regimens, an experienced community oncologist at a well-run hospital can deliver excellent care. The gap between community and academic care has narrowed significantly for many common cancers. Don’t assume you must travel to an NCI center for routine treatment.

Factors that often matter more than designation alone:

• Your oncologist’s individual expertise in your specific cancer
• Center volume — does this center treat many patients with your cancer each year?
• Multidisciplinary coordination — do surgeons, radiation oncologists, and medical oncologists actually review your case together?
• Proximity — long-distance cancer care is hard on patients and families. For common cancers with standard treatment, closer is often better.

Next steps

• Browse NCI-designated cancer centers by state
• Learn about getting a virtual second opinion
• Find clinical trials by cancer type